Analysis of endogenous glutathione-adducts and their metabolites

Biomedical Chromatography

Volumn 24, Issue 1, 2010, Pages 29-38

  Blair, Ian A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Glutathione adducts; LC MS; Leukotrienes; Mercapturic acids; MRM; Stable isotopes

Indexed keywords

BIOMARKERS; BIOMOLECULES; IONS; ISOTOPES; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PEPTIDES;

GLUTATHIONE ADDUCTS; GLUTHATHIONE; LC-MS; LEUKOTRIEN; MERCAPTURIC ACIDS; MULTIPLE REACTION MONITORING; PARENT IONS; PRODUCT IONS; STABLE ISOTOPE DILUTION; STABLE ISOTOPES;

METABOLITES;

CATECHOL ESTROGEN; CYSTEINE DERIVATIVE; CYSTEINYLGLYCINE; GLUTATHIONE DERIVATIVE;

ACCURACY; CHEMICAL REACTION; COLLISIONALLY ACTIVATED DISSOCIATION; CYTOCHEMISTRY; GLUTATHIONE METABOLISM; HUMAN; LIQUID CHROMATOGRAPHY; NONHUMAN; PEPTIDE ANALYSIS; REACTION ANALYSIS; REVIEW; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY;

EID: 75149126749     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.1374     Document Type: Review

References (83)

1. Abrahim A, Al-Sayah M, Skrdla P, Bereznitski Y, Chen Y and Wu N. Practical comparison of 2.7 micron fused-core silica particles and porous sub-2 micron particles for fast separations in pharmaceutical process development. Journal of Pharmaceutical and Biomedical Analysis 2010; 51: 131-137.
2. Alary J, Gueraud F and Cravedi JP. Fate of 4-hydroxynonenal in vivo: disposition and metabolic pathways. Molecular Aspects of Medicine 2003; 24: 177-187.
3. Anders MW. Chemical toxicology of reactive intermediates formed by the glutathione-dependent bioactivation of halogen-containing compounds. Chemical Research in Toxicology 2008; 21: 145-159.
4. Armstrong M, Liu AH, Harbeck R, Reisdorph R, Rabinovitch N and Reisdorph N. Leukotriene-E4 in human urine: comparison of on-line purification and liquid chromatography-tandem mass spectrometry to affinity purification followed by enzyme immunoassay. Journal of Chromatography B Analytical Technologies in the Biomedical and Life Sciences 2009; 877: 3169-3174.
5. Arthur JR. The glutathione peroxidases. Cellular and Molecular Life Sciences 2000; 57: 1825-1835.
6. Awasthi YC, Sharma R, Yadav S, Dwivedi S, Sharma A and Awasthi S. The non-ABC drug transporter RLIP76 (RALBP-1) plays a major role in the mechanisms of drug resistance. Current Drug Metabolism 2007; 8: 315-323.
7. Backlund MG, Mann JR, Holla VR, Buchanan FG, Tai HH, Musiek ES et al. 15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancer. Journal of Biological Chemistry 2005; 280: 3217-3223.
8. Bergholte JM, Soberman RJ, Hayes R, Murphy RC and Okita RT. Oxidation of 15-hydroxyeicosatetraenoic acid and other hydroxy fatty acids by lung prostaglandin dehydrogenase. Archives of Biochemistry and Biophysics 1987; 257: 444-450.
9. Blair IA. Lipid hydroperoxide-mediated DNA damage. Experimental Gerontology 2001; 36: 1473-1481.
10. Blair IA. The role of oxidative stress in cancer and toxicology. In Encyclopedia of Mass Spectrometry, Caprioli RM, Gross ML (eds). Elsevier: Amsterdam, 2005; 283-307.
11. Blair IA. Endogenous glutathione adducts. Current Drug Metabolism 2006; 7: 853-872.
12. Blair IA. DNA-adducts with lipid peroxidation products. Journal of Biological Chemistry 2008; 283: 15545-15549.
13. Blair IA. Analysis of estrogens in serum and plasma from postmenopausal women: past, present, and future. Steroids 2009; in press.
14. Bolton JL and Shen L. p-Quinone methides are the major decomposition products of catechol estrogen o-quinones. Carcinogenesis 1996; 17: 925-929.
15. Bolton JL and Thatcher GR. Potential mechanisms of estrogen quinone carcinogenesis. Chemical Research in Toxicology 2008; 21: 93-101.
16. Bolton JL, Trush MA, Penning TM, Dryhurst G and Monks TJ. Role of quinones in toxicology. Chemical Research in Toxicology 2000; 13: 135-160.
17. Burczynski ME, Sridhar GR, Palackal NT and Penning TM. The reactive oxygen species - and Michael acceptor-inducible human aldo-keto reductase AKR1C1 reduces the alpha,beta-unsaturated aldehyde 4-hydroxy-2-nonenal to 1,4-dihydroxy-2-nonene. Journal of Biological Chemistry 2001; 276: 2890-2897.
18. Carini M, Aldini G and Facino RM. Mass spectrometry for detection of 4-hydroxy-trans-2-nonenal (HNE) adducts with peptides and proteins. Mass Spectrometry Reviews 2004; 23: 281-305.
19. Chandrasena RE, Edirisinghe PD, Bolton JL and Thatcher GR. Problematic detoxification of estrogen quinones by NAD(P)H-dependent quinone oxidoreductase and glutathione-S-transferase. Chemical Research in Toxicology 2008; 21: 1324-1329.
20. Chung FL, Pan J, Choudhury S, Roy R, Hu W and Tang MS. Formation of trans-4-hydroxy-2-nonenal- and other enal-derived cyclic DNA adducts from omega-3 and omega-6 polyunsaturated fatty acids and their roles in DNA repair and human p53 gene mutation. Mutation Research 2003; 531: 25-36.
21. Coles BF and Kadlubar FF. Human alpha class glutathione S-transferases: genetic polymorphism, expression, and susceptibility to disease. Methods in Enzymology 2005; 401: 9-42.
22. Deeley RG, Westlake C and Cole SP. Transmembrane transport of endo-and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins. Physiological Reviews 2006; 86: 849-899.
23. Dieckhaus CM, Fernandez-Metzler CL, King R, Krolikowski PH and Baillie TA. Negative ion tandem mass spectrometry for the detection of glutathione conjugates. Chemical Research in Toxicology 2005; 18: 630-638.
24. Doss GA and Baillie TA. Addressing metabolic activation as an integral component of drug design. Drug Metabolism Reviews 2006; 38: 641-649.
25. Dourado DF, Fernandes PA and Ramos MJ. Mammalian cytosolic glutathione transferases. Current Protein and Peptide Science 2008; 9: 325-337.
26. Griffith OW. Biologic and pharmacologic regulation of mammalian glutathione synthesis. Free Radical Biology and Medicine 1999; 27: 922-935.
27. Gueraud F, Crouzet F, Alary J, Rao D, Debrauwer L, Laurent F et al. Enantioselective metabolism of (R)- and (S)-4-hydroxy-2- nonenal in rat. Biofactors 2005; 24: 97-104.
28. Hardy G, Boizel R, Bessard J, Cracowski JL, Bessard G, Halimi S et al. Urinary leukotriene E4 excretion is increased in type 1 diabetic patients: a quantification by liquid chromatography-tandem mass spectrometry. Prostaglandins and Other Lipid Mediators 2005; 78: 291-299.
29. Haufroid V and Lison D. Mercapturic acids revisited as biomarkers of exposure to reactive chemicals in occupational toxicology: a mini-review. International Archives of Occupational and Environmental Health 2005; 78: 343-354.
30. Hayes JD, Flanagan JU and Jowsey IR. Glutathione transferases. Annual Review of Pharmacology and Toxicology 2005; 45: 51-88.
31. Hazen SL. Oxidized phospholipids as endogenous pattern recognition ligands in innate immunity. Journal of Biological Chemistry 2008; 283: 15527-15531.
32. Hecht SS. Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer. Carcinogenesis 2002; 23: 907-922.
33. Hishinuma T, Suzuki N, Aiba S, Tagami H and Mizugaki M. Increased urinary leukotriene E4 excretion in patients with atopic dermatitis. British Journal of Dermatology 2001; 144: 19-23.
34. Hosgood HD, III, Berndt SI and Lan Q. GST genotypes and lung cancer susceptibility in Asian populations with indoor air pollution exposures: a meta-analysis. Mutation Research 2007; 636: 134-143.
35. Jakobsson PJ, Morgenstern R, Mancini J, Ford-Hutchinson A and Persson B. Membrane-associated proteins in eicosanoid and glutathione metabolism (MAPEG). A widespread protein superfamily. American Journal of Respiratory Critical Care Medicine 2000; 161: S20-S24.
36. Jian W, Arora JS, Oe T, Shuvaev VV and Blair IA. Induction of endothelial cell apoptosis by lipid hydroperoxide-derived bifunctional electrophiles. Free Radical Biology and Medicine 2005a; 39: 1162-1176.
37. Jian W, Lee SH, Arora JS, Silva Elipe MV and Blair IA. Unexpected formation of etheno-2′-deoxyguanosine adducts from 5(S)- hydroperoxyeicosatetraenoic acid: evidence for a bis-hydroperoxide intermediate. Chemical Research in Toxicology 2005b; 18: 599-610.
38. Jian W, Lee SH, Mesaros C, Oe T, Silva Elipe MV and Blair IA. A novel 4-oxo-2(E)-nonenal-derived endogenous thiadiazabicyclo glutathione adduct formed during cellular oxidative stress. Chemical Research in Toxicology 2007; 20: 1008-1018.
39. Jones DP. Redox potential of GSH/GSSG couple: assay and biological significance. Methods in Enzymology 2002; 348: 93-112.
40. Keum YS, Jeong WS and Kong AN. Chemopreventive functions of isothiocyanates. Drug News Perspectives 2005; 18: 445-451.
41. King R, Bonfiglio R, Fernandez-Metzler C, Miller-Stein C and Olah T. Mechanistic investigation of ionization suppression in electrospray ionization. Journal of the American Society of Mass Spectrometry 2000; 11: 942-950.
42. Lam BK and Austen KF. Leukotriene C4 synthase: a pivotal enzyme in cellular biosynthesis of the cysteinyl leukotrienes. Prostaglandins and Other Lipid Mediators 2002; 68-69: 511-520.
43. Lee DH and Jacobs DR, Jr. Is serum gamma-glutamyltransferase a marker of exposure to various environmental pollutants? Free Radical Research 2009; 43: 533-537.
44. Lee SH and Blair IA. Oxidative DNA damage and cardiovascular disease. Trends in Cardiovascular Medicine 2001; 11: 148-155.
45. Lee SH, Oe T and Blair IA. Vitamin C-induced decomposition of lipid hydroperoxides to endogenous genotoxins. Science 2001; 292: 2083-2086.
46. Lee SH, Silva Elipe MV, Arora JS and Blair IA. Dioxododecenoic acid: a lipid hydroperoxide-derived bifunctional electrophile responsible for etheno DNA adduct formation. Chemical Research in Toxicology 2005; 18: 566-578.
47. Lee SH, Rangiah K, Williams MV, Wehr AY, Dubois RN and Blair IA. Cyclo-oxygenase-2-mediated metabolism of arachidonic acid to 15-oxoeicosatetraenoic acid by rat intestinal epithelial cells. Chemical Research in Toxicology 2007; 20: 665-1675.
48. Levsen K, Schiebel HM, Behnke B, Dotzer R, Dreher W, Elend M et al. Structure elucidation of phase II metabolites by tandem mass spectrometry: an overview. Journal of Chromatography A 2005; 1067: 55-72.
49. Lu SC. Regulation of glutathione synthesis. Current Topics in Cellular Regulation 2000; 36: 95-116.
50. Ma L, Wen B, Ruan Q and Zhu M. Rapid screening of glutathione-trapped reactive metabolites by linear ion trap mass spectrometry with isotope pattern-dependent scanning and postacquisition data mining. Chemical Research in Toxicology 2008; 21: 1477-1483.
51. Mangal D, Vudathala DK, Park JH, Lee SH, Penning TM and Blair IA. Analysis of 7,8-dihydro-8-oxo-2′-deoxyguanosine in cellular DNA during oxidative stress. Chemical Research in Toxicology 2009; 22: 788-797.
52. Milne GL, Yin H and Morrow JD. Human biochemistry of the isoprostane pathway. Journal of Biological Chemistry 2008; 283: 15533-15537.
53. Minko IG, Kozekov ID, Harris TM, Rizzo CJ, Lloyd RS and Stone MP. Chemistry and biology of DNA containing 1,N(2)-deoxyguanosine adducts of the alpha,beta-unsaturated aldehydes acrolein, crotonaldehyde, and 4-hydroxynonenal. Chemical Research in Toxicology 2009; 22: 759-778.
54. Mizugaki M, Hishinuma T and Suzuki N. Determination of leukotriene E4 in human urine using liquid chromatography-tandem mass spectrometry. Journal of Chromatography B Analytical Technologies in the Biomedical and Life Sciences 1999; 729: 279-285.
55. Murakami M and Kudo I. Prostaglandin E synthase: a novel drug target for inflammation and cancer. Current Pharmaceutical Design 2006; 12: 943-954.
56. Murphy RC and Zarini S. Glutathione adducts of oxyeicosanoids. Prostaglandins and Other Lipid Mediators 2002; 68-69: 471-482.
57. Nakamura H, Hishinuma T, Suzuki N, Chiba S, Tsukamoto H, Takabatake M et al. Diff erence in urinary 11-dehydro TXB2 and LTE4 excretion in patients with rheumatoid arthritis. Prostaglandins Leukotrienes and Essential Fatty Acids 2001; 65: 301-306.
58. Oe T, Ackermann BL, Inoue K, Berna MJ, Garner CO, Gelfanova V et al. Quantitative analysis of amyloid beta peptides in cerebrospinal fluid of Alzheimer's disease patients by immunoaffinity purification and stable isotope dilution liquid chromatography/negative electrospray ionization tandem mass spectrometry. Rapid Communications in Mass Spectrometry 2006; 20: 3723-3735.
59. Peiro G, Alary J, Cravedi JP, Rathahao E, Steghens JP and Gueraud F. Dihydroxynonene mercapturic acid, a urinary metabolite of 4-hydroxynonenal, as a biomarker of lipid peroxidation. Biofactors 2005; 24: 89-96.
60. Pierre F, Peiro G, Tache S, Cross AJ, Bingham SA, Gasc N et al. New marker of colon cancer risk associated with heme intake: 1,4-dihydroxynonane mercapturic acid. Cancer Epidemiology Biomarkers and Prevention 2006; 15: 2274-2279.
61. Pombrio JM, Giangreco A, Li L, Wempe MF, Anders MW, Sweet DH et al. Mercapturic acids (N-acetylcysteine S-conjugates) as endogenous substrates for the renal organic anion transporter-1. Molecular Pharmacology 2001; 60: 1091-1099.
62. Rinaldi R, Eliasson E, Swedmark S and Morgenstern R. Reactive intermediates and the dynamics of glutathione transferases. Drug Metabolism and Disposition 2002; 30: 1053-1058.
63. Schafer FQ and Buettner GR. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radical Biology and Medicine 2001; 30: 1191-1212.
64. Scherer G, Urban M, Hagedorn HW, Feng S, Kinser RD, Sarkar M et al. Determination of two mercapturic acids related to crotonaldehyde in human urine: influence of smoking. Human and Experimental Toxicology 2007; 26: 37-47.
65. Schneider C, Tallman KA, Porter NA and Brash AR. Two distinct pathways of formation of 4-hydroxynonenal. Mechanisms of nonenzymatic transformation of the 9- and 13-hydroperoxides of linoleic acid to 4-hydroxyalkenals. Journal of Biological Chemistry 2001; 276: 20831-20838.
66. Sharma R, Yang Y, Sharma A, Awasthi S and Awasthi YC. Antioxidant role of glutathione S-transferases: protection against oxidant toxicity and regulation of stress-mediated apoptosis. Antioxidants and Redox Signaling 2004; 6: 289-300.
67. Shen XM, Xia B, Wrona MZ and Dryhurst G. Synthesis, redox properties, in vivo formation, and neurobehavioral eff ects of N-acetylcysteinyl conjugates of dopamine: possible metabolites of relevance to Parkinson's disease. Chemical Research in Toxicology 1996; 9: 1117-1126.
68. Sidell KR, Amamath V and Montine TJ. Dopamine thioethers in neurodegeneration. Current Topics in Medicinal Chemistry 2001; 1: 519-527.
69. Stanke-Labesque F, Pofelski J, Moreau-Gaudry A, Bessard G and Bonaz B. Urinary leukotriene E4 excretion: a biomarker of inflammatory bowel disease activity. Inflammatory Bowel Diseases 2008; 14: 769-774.
70. Stevens JF and Maier CS. Acrolein: sources, metabolism, and biomolecular interactions relevant to human health and disease. Molecular Nutrition and Food Research 2008; 52: 7-25.
71. Suzuki N, Hishinuma T, Abe F, Omata K, Ito S, Sugiyama M et al. Diff erence in urinary LTE4 and 11-dehydro-TXB2 excretion in asthmatic patients. Prostaglandins and Other Lipid Mediators 2000; 62: 395-403.
72. Tang W. The metabolism of diclofenac - enzymology and toxicology perspectives. Current Drug Metabolism 2003; 4: 319-329.
73. Uchida K. 4-Hydroxy-2-nonenal: a product and mediator of oxidative stress. Progress in Lipid Research 2003; 42: 318-343.
74. Völkel W, varez-Sanchez R, Weick I, Mally A, Dekant W and Pahler A. Glutathione conjugates of 4-hydroxy-2(E)-nonenal as biomarkers of hepatic oxidative stress-induced lipid peroxidation in rats. Free Radical Biology and Medicine 2005; 38: 1526-1536.
75. Völkel W, Sicilia T, Pahler A, Gsell W, Tatschner T, Jellinger K et al. Increased brain levels of 4-hydroxy-2-nonenal glutathione conjugates in severe Alzheimer's disease. Neurochemistry International 2006; 48: 679-686.
76. Wagner S, Scholz K, Sieber M, Kellert M and Völkel W. Tools in metabonomics: an integrated validation approach for LC-MS metabolic profiling of mercapturic acids in human urine. Analytical Chemistry 2007; 79: 2918-2926.
77. Wei C, Zhu P, Shah SJ and Blair IA. 15-Oxo-eicosatetraenoic acid, a metabolite of macrophage 15-hydroxyprostaglandin dehydrogenase that inhibits endothelial cell proliferation. Molecular Pharmacology 2009; 76: 516-529.
78. White DL, Li D, Nurgalieva Z and El-Serag HB. Genetic variants of glutathione S-transferase as possible risk factors for hepatocellular carcinoma: a HuGE systematic review and meta-analysis. American Journal of Epidemiology 2008; 167: 377-389.
79. Zarini S, Gijon MA, Ransome AE, Murphy RC and Sala A. Transcellular biosynthesis of cysteinyl leukotrienes in vivo during mouse peritoneal inflammation. Proceedings of the National Academy of Sciences USA 2009; 106: 8296-8301.
80. Zhou X, Taghizadeh K and Dedon PC. Chemical and biological evidence for base propenals as the major source of the endogenous M1dG adduct in cellular DNA. Journal of Biological Chemistry 2005; 280: 25377-25382.
81. Zhou ZD and Lim TM. Roles of glutathione (GSH) in dopamine (DA) oxidation studied by improved tandem HPLC plus ESI-MS. Neurochemical Research 2009; 34: 316-326.
82. Zhu P, Oe T and Blair IA. Determination of cellular redox status by stable isotope dilution liquid chromatography/mass spectrometry analysis of glutathione and glutathione disulfide. Rapid Communications in Mass Spectrometry 2008; 22: 432-440.
83. Zhu P, Jian W and Blair IA. A 4-oxo-2(E)-nonenal-derived glutathione adduct from 15-lipoxygenase-1-mediated oxidation of cytosolic and esterified arachidonic acid. Free Radical Biology and Medicine 2009; 47: 953-961.